百潤股份(002568.SZ)披露定增報告書:由易方達與東證資管全部認購
格隆匯 11 月 18日丨百潤股份(002568.SZ)披露非公開發行股票發行情況報告書暨上市公告書,根據投資者的報價情況及《認購邀請書》中規定的發行對象和認購價格的確定原則,百潤股份與保薦機構(主承銷商)共同協商確定此次發行價格為62.68元/股,發行數量為1604.9776萬股,募集資金總額約10.06億元。
此次發行的發行對象及其具體獲配股數如下:


股票上市時間:2020年11月23日,此次發行新增股份上市首日公司股價不除權,股票交易設漲跌幅限制。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.